PEPR1 Mediates SsNLP1-Triggered Immunity Against Sclerotinia sclerotiorum
International Journal of Molecular Sciences · 10.06.2026 · 27 (12) · 5271
DOI: 10.3390/ijms27125271 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.06.2026. Verfasst von Imtiaz Ahmad Sajid und 3 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Biology and Ecological Regulation of Crop Pathogens and Insects, Institute of Biotechnology, College of Agriculture and Bi…. Hauptthemen laut MEDLINE: Ascomycota, Arabidopsis, Plant Diseases, Plant Immunity. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hainan Provincial Natural Science Foundation of China, Zhejiang Agricultural Core Technology Research and Development Project.
Abstract (Originalsprache)
Necrosis- and ethylene-inducing peptide 1 (Nep1)-like proteins (NLPs) are conserved microbial proteins that contain immunogenic patterns capable of activating plant pattern-triggered immunity (PTI). NLP patterns from Sclerotinia sclerotiorum (SsNLPs), a destructive necrotrophic fungal pathogen with a broad host range, have been identified, and their roles in PTI have been revealed. Nevertheless, the molecular mechanisms by which SsNLPs stimulate plant immunity remain largely unknown. In this study, we phylogenetically characterized SsNLPs and demonstrated the involvement of the phytocytokine receptor-like kinases PEPRs in SsNLP1-triggered immunity. SsNLPs contained the NPP1 domain and GHRHDWE motif and were phylogenetically closely associated with Botrytis cinerea NLPs. SsNLP1 treatment strongly induced the expression of PEPR genes. Further genetic analyses using Arabidopsis wild-type, pepr1 pepr2 double mutant, and PEPR1 overexpression lines showed that SsNLP1 elicited diverse immune responses, including reactive oxygen species (ROS) accumulation and defense gene activation, and induced plant resistance to S. sclerotiorum. Notably, the induced plant resistance and immune responses were strengthened in PEPR1 overexpression lines and significantly reduced in the pepr1 pepr2 mutant, indicating a positive role of PEPR signaling in SsNLP1-triggered immunity. Overall, our results revealed that phytocytokine PEPR1 signaling amplifies PAMP SsNLP1-triggered immunity, thereby enhancing resistance against S. sclerotiorum. Our findings provide an example of the coordination between PAMP- and phytocytokine-triggered immunity for robust resistance to a necrotrophic pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Biology and Ecological Regulation of Crop Pathogens and Insects, Institute of Biotechnology, College of Agriculture and Biotechnology, Zhejiang University, 866 Yu Hang Tang Road, Hangzhou 3100…
- Institute of Crop Science, College of Agriculture and Biotechnology, Zhejiang University, Hangzhou 310058, China.
- Hainan Institute, Zhejiang University, Sanya 572025, China.
ORCID-Profile: Muhammad Kamran, Xin-Zhong Cai
Förderung
- Hainan Provincial Natural Science Foundation of China
- Zhejiang Agricultural Core Technology Research and Development Project
Zitieren
APA
Sajid, I. A., Kamran, M., Gishkori, Z. G. N., & Cai, X. Z. (2026). PEPR1 Mediates SsNLP1-Triggered Immunity Against Sclerotinia sclerotiorum. International Journal of Molecular Sciences, 27(12), 5271. https://doi.org/10.3390/ijms27125271
Vancouver
Sajid IA, Kamran M, Gishkori ZGN, Cai XZ. PEPR1 Mediates SsNLP1-Triggered Immunity Against Sclerotinia sclerotiorum. International Journal of Molecular Sciences. 2026;27(12):5271. doi:10.3390/ijms27125271
BibTeX
@article{Sajid2026,
author = {Sajid, Imtiaz Ahmad and Kamran, Muhammad and Gishkori, Zeeshan Ghulam Nabi and Cai, Xin-Zhong},
title = {PEPR1 Mediates SsNLP1-Triggered Immunity Against Sclerotinia sclerotiorum},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5271},
doi = {10.3390/ijms27125271}
}
EUVIMED